PCI has excellent outcomes for younger adults with coronary artery disease

June 6, 2012
PCI has excellent outcomes for younger adults with CAD

(HealthDay) -- For younger adults with premature coronary artery disease (CAD), percutaneous coronary intervention (PCI) is associated with excellent short- and long-term outcomes, according to a study published in the June 15 issue of The American Journal of Cardiology.

Emanuele Meliga, M.D., Ph.D., of the Mauriziano Hospital in Turin, Italy, and colleagues conducted a retrospective study involving 214 consecutive patients, 40 years of age or younger, who underwent PCI for premature CAD with a bare-metal or drug-eluting stent. The immediate and long-term clinical outcomes were assessed.

The researchers found that a total of 272 stents were implanted, including 154 bare-metal stents and 118 drug-eluting stents. No patients died in the hospital, and the incidence of major cardiac and cerebrovascular events was 2.3 percent. After a median of 757 days of follow-up, 0.9 percent of patients had died and 12.6 percent required a new revascularization procedure. At the median follow-up point and at 1,818 days, the major adverse cardiac and cerebrovascular event-free survival rates were 89.6 and 84.2 percent, respectively. Independent predictors of events included active smoking and having a under 50 percent.

"In conclusion, PCI in young patients [leads] to excellent results in short- and long-term follow-up and should be considered as the treatment of choice," the authors write. "Traditional risk factors are important prognostic determinants of adverse events and might help identify higher-risk patients within this cohort."

Explore further: Positive results for unprotected left main coronary artery PCI with drug-eluting stents

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Recommended for you

Heart attack treatment hypothesis 'busted'

July 6, 2015

Researchers have long had reason to hope that blocking the flow of calcium into the mitochondria of heart and brain cells could be one way to prevent damage caused by heart attacks and strokes. But in a study of mice engineered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.